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Abstract 
Blood transfusions are costly and increase morbidity and mortality [1,2,3]. Transfusion decisions are guided by the value of 
hemoglobin in patients. The worldwide current practice of obtaining this data is based in intermittent, invasive measurements of 
hemoglobin that are sent to the laboratory. This procedure may contribute to unnecessary and inappropriate blood transfusions 
that account for 10% [4] of the total amount of transfusions, due to the uncertainty given by the delay in receiving the data back 
from the lab and the difficulty associated in the detection of internal bleeding. The use of a new procedure to obtain hemoglobin 
value, based in real-time monitoring, may allow physicians to initiate timely blood transfusions and avoid giving unnecessary 
ones. A literature search will be done to demonstrate a reduction in transfusions with this new monitoring method and the 
associated savings in costs.  
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1. Introduction  
Blood plays an important role in regulating the body's systems and maintaining homeostasis. It performs many 
functions within the body, including: 
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x Supplying oxygen to tissues (bound to hemoglobin, which is carried in red cells).  
x Supplying nutrients bound to plasma proteins.  
x Removing waste such as carbon dioxide, urea, and lactic acid.   
x Messenger functions, including the transport of hormones and the signaling of tissue damage.   
 
The protein hemoglobin was discovered by Hünefeld in 1840, while the role of hemoglobin in the blood as an 
oxygen-carrying protein was elucidated by French physiologist Claude Bernard. 
Blood transfusion is generally the process of receiving blood products into one's circulation intravenously. 
Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions 
used whole blood, but modern medical practice commonly uses only components of the blood, such as red blood 
cells, white blood cells, plasma, clotting factors, and platelets. 
During surgical procedures bleeding is caused by the breaking of blood vessels. It is a necessary adverse effect, 
but some of the internal bleedings are difficult to detect and quantify.  
Continuous bleeding derives in a continuous reduction of the Hemoglobin value in patients. Transfusion 
decision-making is determined by this patient’s hemoglobin value and when the hemoglobin reaches a certain low 
value, the transfusion is mandatory. 
While necessary, transfusions of blood products are associated with several complications, many of which can be 
grouped as immunological or infectious. While some complication risks depend on patient status or specific 
transfusion quantity involved, a baseline risk of complications simply increases in direct proportion to the frequency 
and volume of transfusion. 
As a resume, blood transfusions are costly and increase patient risk, morbidity and mortality that result from the 
diseases caused by the adverse secondary effects inherent in transfusions. This morbidity and mortality result in 
health and economic costs.  
Any new procedure or methodology that can reduce the number of unnecessary transfusions will derive in a 
better and more cost-efficient health system. 
2. Current situation of obtaining Hemoglobin value in Hospitals. 
Hemoglobin concentration measurement is among the most commonly performed blood tests. Laboratory 
hemoglobin test methods require a blood sample and analysis on hematology analyzer. 
The current practice of obtaining the hemoglobin value of a patient during surgeries is based in two methods: 
2.1. Analytical method: 
This method is based in intermittent, invasive measurements of hemoglobin that are sent to the laboratory. The 
laboratory, once processed the blood sample, sends to the operating room the analytical report. The value of the 
Hemoglobin is expressed in grams per deciliter (g/dl). In the analytical reports, hemoglobin is shown with the 
acronym of Hb. 
2.2. Qualitative and Quantitative method: 
Based in their expertise, physicians calculate the amount of blood drawn in the reservoir during the surgery and 
translate the volume into g/dl, deducting that value to the prior hemoglobin value of the patient shown in the pre-
surgical consultation.  
This current methodology may contribute to unnecessary and inappropriate blood transfusions that account for 
10% [4] of the total amount of transfusions, due to the uncertainty given by the delay in receiving the data back from 
the lab between blood draw and laboratory analysis and the difficulty associated in the detection of internal 
bleeding. 
The use of a new procedure to obtain hemoglobin value, based in continuous monitoring and measurement, may 
allow physicians to initiate timely blood transfusions and avoid giving unnecessary ones. 
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Furthermore, non-invasive and continuous hemoglobin monitoring provides real-time trends in the direction of 
Hb, such as indicating stable Hb when it may be perceived to be dropping and rising Hb when it may be perceived 
to not be rising fast enough.  
3. Materials 
3.1. The Rainbow Radical-7 Pulse CO-Oximeter  
Radical-7 is a non-invasive, arterial oxygen saturation, total haemoglobin concentration and pulse rate monitor. 
 
Fig 1. Rainbow® Pulse CO-Oximetry with Total Hemoglobin (SpHb®) continuous Measurement. [5] 
It is indicated for the continuous, non-invasive monitoring of functional oxygen saturation of arterial hemoglobin 
(SpO2), pulse rate and total hemoglobin concentration expressed in grams per deciliter (SpHb). 
The principle of operation is as follows: 
 
Using spectrophotometry, oxyhemoglobin (oxygenated blood), deoxyhemoglobin (non-oxygenated blood), 
carboxyhemoglobin (blood with carbon monoxide content) and methemoglobin (blood with oxidized hemoglobin) 
differ in their absorption of visible and infrared light  
 
 
Fig 2. Absorption spectra of blood components 
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The amount of arterial blood in tissue changes with your pulse (photoplethysmography). Therefore, the amount 
of light absorbed by the varying quantities of arterial blood changes as well. 
3.2. The SpHb® Sensor 
The Radical-7 utilizes a sensor with various light-emitting diodes, LEDs (number 1 in Figure 3) that pass light 
through the site to a diode (detector) (number 2 in Figure 3). 
 
Fig 3. Sensor technology 
Signal data is obtained by passing numerous visible and infrared lights (LEDs, 500 to 1400nm) through a 
capillary bed (for example, a fingertip, a hand, a foot) and determining and measuring changes in light absorption 
during the blood pulsatile cycle.  
The detector receives the light, converts it into an electronic signal and sends it to the Radical-7 for calculation. 
4. Methods 
A literature search based on articles, texts, corporation webpages, encyclopedias and books of recent studies will 
be done to demonstrate: 
 
x Quality of the sensor: To demonstrate the quality of the sensor, the correlation between sensor and laboratory 
analysis (current invasive universally used method) will be studied. 
x Efficiency: Besides the medical improvement of obtaining additional real-time clinical values of the patients, the 
effectiveness of the new methodology is based on an expected reduction in blood transfusions when real-time 
monitoring of hemoglobin is used.  
x Cost savings: Blood transfusions are costly (directly and indirectly by the increase of morbidity and mortality 
associated to them). Multiplying transfusions saved by this new method with the cost of each transfusion will 
show the economic savings of this procedure. 
5. Results 
5.1. Correlation. RADICAL-7 vs. Laboratory Analysis (drawn whole blood measurements)  
When SpHb® (continuous hemoglobin monitoring) measurements obtained from the Radical-7 are compared to 
drawn whole blood (invasive) measurements by laboratory analytical methods, caution should be taken when 
evaluating and interpreting the results.  
The laboratory CO-Oximetry measurements may differ from the SpHb® measurements of the Radical-7 Pulse 
CO-Oximeter. 
There are multiple studies of the correlation between both methods. Good correlation in this clinical parameter 
should be less than 1.5 g/dl. All studies where made using Masimo™ Radical-7 Pulse CO-Oximeter, in voluntary 
adult patients: 
 
x Masimo™  technical bulletin 1 [6]: In 11,335 comparisons of SpHb and invasive hemoglobin (tHb) 
measurements from a laboratory reference device, SpHb accuracy was -0.02 g/dl. bias and 0.99 g/dl. at one 
standard deviation. 
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Fig 4. Normal Sensitivity Scatter Plot of SpHb Vs tHb measurements [6] 
x Frasca and Mimoz study [7]: In 471 comparisons of SpHb and invasive hemoglobin (tHb) measurements from a 
laboratory reference device, the bias and limits of agreement were 0.0 ± 1.0g/dL for the Pulse CO-Oximeter.  
x Masimo™  Technical Bulletin 2 [8]: In 492 comparisons of SpHb readings with invasive hemoglobin (tHb) 
measurements taken at the same time and analyzed by a laboratory CO-Oximeter, SpHb had a correlation of 0.90, 
a standard deviation of 0.95 g/dl.  
x Berkow and colleagues [9]: An investigation of the accuracy of SpHb compared to laboratory CO-Oximetry 
measurement of 130 arterial blood samples from 29 complex spine surgery patients showed a bias and precision 
(defined as 1 SD of the bias) of -0.1 g/dl. ± 1.0 g/dl.  
x Lamhaut et al. [10] obtained a total of 85 measurements, which showed a bias of only −0.02 g/dl. (SD 1.39) and a 
precision of 1.11 g/dl. (SD 0.83).  
5.2. Reduction in transfusions  
Once observed the correlation between both methods of obtaining Hemoglobin values, there are several studies 
in which the reduction of the total amount of transfusions is analyzed: 
 
x Awada & Maher study [4]: A total of 106 orthopaedic patients were enrolled a prospective cohort study at an 
academic, tertiary hospital. The study showed a 10% reduction in blood transfusions (from 49% to 44%) as 
follows: 
   Table 1. Blood transfusions in Awada study [4] 
 Standard Care Group SpHb Group 
Patients 61 45 
Transfused (N) 43 30 
Transfused (N) 49% 44% 
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x Ehrenfeld, Henneman & Sangber study [11]: A total of 327 patients were enrolled (157 standard care, 170 
SpHb® monitored) in a prospective, randomized, controlled trial to assess the impact of SpHb® monitoring upon 
transfusions in patients undergoing elective orthopaedic surgery during a six month period. The results are a drop 
of 86% in transfusions as shown in Table 2. This amazing drop compared to the Awada study may be due to the 
lower prevalence of blood transfusion among this type of patients: 
       Table 2. Blood transfusions in Ehrenfeld study [11] 
 Standard Care Group SpHb Group 
Patients 157 170 
Transfused (N) 7 1 
Transfused (N) 4.5% 0.6% 
 
5.3. Transfusion Costs  
Health costs vary widely worldwide. Depending on the country, transfusion costs (linked to an increase in 
mortality and morbidity) can vary. Data from four systematic studies [12-15] estimated the cost per unit of 
transfused RBCs from $332 to $717 in 2008.  
To accurately determine the cost of blood in a surgical population from a health system perspective, an activity-
based costing (ABC) model was constructed in a study [16] where Tasks and resource consumption (materials, 
labour, third-party services and capital) related to blood administration were identified prospectively at two US and 
two European hospitals. The new methodology showed that the real cost of blood transfusions was in the range of 
$522 and $1,183 (mean, $761 ± $294). This study presented the cost of transfusions in two US hospitals and two 
European hospitals (Austria and Switzerland). 
In Spain, a study made in 2007 [17] showed that the cost of a transfusion for the health care system was 350€.  
Overall, adverse events from transfusions, for example in the US, account for about $17 Billion , and in effect 
add more to the cost of each transfusion than acquisition and procedure costs combined [18]. 
When mentioning Hospital units or departments, SpHb real-time monitoring could contribute to $93,600 in net 
annual cost savings in a typical surgical department and $67,350 in an intensive care department [19]. 
6. Conclusions 
In this study there have been analysed five different studies showing accuracy and correlation while two of them 
showed also blood transfusion savings and effectiveness when Masimo™ Radical-7 Pulse Co-oxymeter and the 
SpHb sensor is used in comparison with the invasive, traditional measurement procedures.  
In terms of economic savings associated to the blood transfusion procedure, eight studies where analysed.  
Healthcare institutions are under increasing pressure to improve the quality and safety of patient care while 
improving efficiencies and decreasing costs. 
Therefore, a decrease in health cost, while improving patient safety, is expected when using this new 
measurement methodology.  
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